New combo therapy aims to shrink head and neck tumors
Disease control
Recruiting now
This study tests whether adding an experimental drug called VS-101 to standard chemoradiotherapy helps control head and neck cancer better than standard treatment alone. About 30 adults with squamous cell carcinoma of the mouth, throat, or voice box will take part. The main goal …
Phase: PHASE2 • Sponsor: VSPharmTech Co.,Ltd. • Aim: Disease control
Last updated May 05, 2026 11:53 UTC